Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC)

Name: Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC)
License: Public Domain

National Health Research Institutes, Taiwan

ClinicalTrials.gov · Datasets · License: Public Domain

hepatocellular carcinoma (hcc)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 429763
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.